Results 21 to 30 of about 4,025 (237)

SAFA initiates innate immunity against cytoplasmic RNA virus SFTSV infection

open access: yesPLoS Pathogens, 2021
Nuclear scaffold attachment factor A (SAFA) is a novel RNA sensor involved in sensing viral RNA in the nucleus and mediating antiviral immunity. Severe fever with thrombocytopenia syndrome virus (SFTSV) is a bunyavirus that causes SFTS with a high ...
Bin-yan Liu, Xue-jie Yu, Chuan-min Zhou
doaj   +5 more sources

Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-κB signaling pathway

open access: hybridJournal of Virology
Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne bunyavirus with high pathogenicity. There has been a gradual increase in the number of reported cases in recent years, with high morbidity and mortality rates. The cyclic
Yupei Jia   +8 more
openalex   +2 more sources

The immunogenicity and protection efficacy evaluation of mRNA vaccine candidate for severe fever with thrombocytopenia syndrome in mice. [PDF]

open access: yesPLoS Neglected Tropical Diseases
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne viral pathogen that causes Severe fever with thrombocytopenia syndrome (SFTS) in humans with a high fatality rate.
Da-Eun Jeong   +3 more
doaj   +2 more sources

Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development [PDF]

open access: goldViruses
SFTSV is an emerging tick-borne virus causing hemorrhagic fever with a case fatality rate (CFR) that can reach up to 27%. With endemic infection in East Asia and the recent spread of the vector tick to more than 20 states in the United States, the SFTSV ...
Do-Kyun Kim   +3 more
openalex   +2 more sources

Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice

open access: yesnpj Vaccines
Severe fever with thrombocytopenia syndrome (SFTS) is caused by the SFTS virus (SFTSV) with high morbidity and mortality. The major immunodominant region of SFTSV surface glycoprotein (G) remains unclear.
Hua Qian   +9 more
doaj   +2 more sources

Discovery of novel Favipiravir derivatives with improved pharmacokinetic properties as anti-SFTSV agents

open access: goldEuropean Journal of Medicinal Chemistry Reports
Favipiravir is a nucleobase analogue that exhibits antiviral activities against a variety of RNA viruses. Due to the lack of antivirals to combat SFTS, an emerging tickborne epidemic caused by a RNA virus belonging to the Phenuividae family within Bunyavirales, Favipiravir has been put brand new attention as optimal SFTS clinical candidate.
Xiaomeng He   +7 more
semanticscholar   +4 more sources

SFTSV nucleoprotein mediates DNA sensor cGAS degradation to suppress cGAS-dependent antiviral responses

open access: yesMicrobiology Spectrum
Cyclic GMP-AMP synthase (cGAS) is an important DNA pattern recognition receptor that senses double-stranded DNA derived from invading pathogens or self DNA in cytoplasm, leading to an antiviral interferon response.
Ze-zheng Jiang   +9 more
doaj   +2 more sources

Knockout of CLTC gene reduces but not completely block SFTSV infection

open access: yesPLOS ONE, 2023
Clathrin is a key protein for viruses to enter host cells. Previous studies often use clathrin inhibitors or gene knockdown technology to partially inhibit the function of clathrin, but whether SFTSV can infect host cells without clathrin expression ...
Tiezhu Liu   +11 more
semanticscholar   +4 more sources

Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model

open access: hybridProceedings of the National Academy of Sciences of the United States of America
Significance Severe fever with thrombocytopenia syndrome virus (SFTSV) is one of the bunyaviruses that caused severe clinical symptoms with a mortality rate ranging from 5 to 30%.
Zhen Chang   +17 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy